Trial Details

COMPLETED
Basic Information
Clinical ID c1086
Identifier NCT03290781
Trial Title An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis
Interventions DRUG: Ontamalimab|OTHER: Placebo
Participant Information
Sponsor Shire
City Mesa
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2018-04-04
Primary Completion Date 2021-07-01
Completion Date 2021-07-01